These include aggressive epidermotropic CD8+ CTCL, cutaneous γ/δ T-cell lymphoma (including cases formerly diagnosed as SPLTCL with a γ/δ phenotype) and primary cutaneous small–medium CD4+ T-cell lymphoma. The gene discussed is CD4; the disease is T-cell non-Hodgkin lymphoma.